Israel Englander’s Liminatus Pharma Warrants LIMNW Stock Holding History

Israel Englander’s Portfolio LIMNW Stock Details LIMNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.3K	Hold	70,616	–	–	﹤0.01%	5743
2026 Q1	$2.83K	Hold	70,616	–	–	﹤0.01%	5585
2025 Q4	$2.47K	Hold	70,616	–	–	﹤0.01%	5913
2025 Q3	$10.4K	Hold	70,616	–	–	﹤0.01%	5895
2025 Q2	$16.9K	Buy	+70,616	New	+$13.9K	﹤0.01%	5695

Other funds holding LIMNW

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return